Article info
PDFShort report
A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations
- Correspondence to Diana Eccles, Wessex Clinical Genetics Service, Southampton University Hospitals Trust, Princess Anne Hospital, Level G, Southampton SO16 5YA, UK; d.m.eccles{at}soton.ac.uk
Citation
A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations
Publication history
- Received February 18, 2010
- Revised April 27, 2010
- First published August 30, 2010.
Online issue publication
January 17, 2017
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.